XML 69 R21.htm IDEA: XBRL DOCUMENT v2.4.0.6
Summary of Significant Accounting Policies (Tables)
3 Months Ended
Mar. 31, 2013
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]  
Reconciliation of the numerators and denominators used in computing basic and diluted net income per share
                 
    Three Months Ended  
    March 31,
2013
    March 31,
2012
 

Net income (loss)

  $ (9,665,379   $ (5,481,799

Cumulative dividends on Series G Preferred Stock

    —         (10,000
   

 

 

   

 

 

 

Numerator, basic and diluted net income (loss) available to stockholders

  $ (9,665,379   $ (5,491,799
   

 

 

   

 

 

 
     

Denominator:

               

Shares used in computation – basic:

               

Weighted average common shares outstanding

    77,344,388       73,165,136  
   

 

 

   

 

 

 
     

Shares used in computation – diluted:

               

Weighted average common shares outstanding

    77,344,388       73,165,136  

Dilutive effect of potential common shares outstanding

    —         —    
   

 

 

   

 

 

 

Shares used in computing diluted net income per share

    77,344,388       73,165,136  
   

 

 

   

 

 

 
     

Net income (loss) per share – basic

  $ (0.12   $ (0.08

Net income (loss) per share – diluted

  $ (0.12   $ (0.08
In the money potential common shares [Member]
 
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]  
Schedule of antidilutive securities excluded from computation of earnings per share
                 
    Three Months Ended  
    March 31,
2013
    March 31,
2012
 

Average market price during the period

  $ 3.24     $ 3.18  
     

In the money potential common shares from options excluded

    396,105       269,699  

In the money potential common shares from warrants excluded

    555,877       1,202,529  
Out of money potential common shares [Member]
 
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]  
Schedule of antidilutive securities excluded from computation of earnings per share
                 
    Three Months Ended  
    March 31,
2013
    March 31,
2012
 
     

Out of the money options and warrants excluded:

               

Stock options with an exercise price of $3.30 per share

    100,000       —    

Stock options with an exercise price of $3.43 per share

    40,000       —    

Stock options with an exercise price of $3.50 per share

    345,000       245,000  

Stock options with an exercise price of $3.51 per share

    959,500       984,670  

Stock options with an exercise price of $3.53 per share

    194,100       211,900  

Stock options with an exercise price of $3.90 per share

    20,000       —    

Stock options with an exercise price of $4.00 per share

    52,500       52,500  

Stock options with an exercise price of $5.00 per share

    200,000       400,000  

Stock options with an exercise price of $7.00 per share

    100,000       100,000  

Warrants with an exercise price of $4.32 per share

    —         1,302,083  

Warrants with an exercise price of $3.60 per share

    1,562,500       —    

Warrants with an exercise price of $5.25 per share

    —         100,000  
   

 

 

   

 

 

 

Total anti-dilutive warrants and options excluded from EPS

    3,573,600       3,396,153  
   

 

 

   

 

 

 
Convertible preferred stock excluded from EPS [Member]
 
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]  
Schedule of antidilutive securities excluded from computation of earnings per share
                 
    Three Months Ended  
    March 31,
2013
    March 31,
2012
 
     

Potential common shares from Convertible Preferred Stock excluded from EPS

    206,400       346,400  
   

 

 

   

 

 

 
Unvested restricted stock awards excluded from EPS [Member]
 
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]  
Schedule of antidilutive securities excluded from computation of earnings per share
                 
    Three Months Ended  
    March 31,
2013
    March 31,
2012
 
     

Potential common shares from unvested restricted stock awards excluded from EPS

    505,503       495,304